BIOSENIX
Biosenix is a medical technology company that develops wearable medical devices for monitoring the health of the elderly. The company was founded in 2018 in Tucson, Arizona.
BIOSENIX
Social Links:
Industry:
Health Care Medical Device Wearables
Founded:
2018-01-01
Address:
Tucson, Arizona, United States
Country:
United States
Website Url:
http://www.biosenix.com
Total Employee:
1+
Status:
Active
Total Funding:
224.6 K USD
Similar Organizations
Sensome
Sensome offers micro-sensor technology to turn medical devices into connected healthcare devices.
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - Biosenix
Official Site Inspections
http://www.biosenix.com
- Host name: ec2-52-20-84-62.compute-1.amazonaws.com
- IP address: 52.20.84.62
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Biosenix"
About Us | BioSenic
BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of innate immunity, inflammation and organ/function repair. ... (2013-2014), …See details»
BioSenic - Crunchbase Company Profile & Funding
Organization. BioSenic . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... BioSenic is a forward-thinking firm that aims to address critical unmet medical needs in the fields of …See details»
Investors - BioSenic
May 27, 2024 BioSenic SA Rue Granbonpré 11 – Bâtiment H (bte 24) 1435 Mont-St-Guibert – Belgium T.: +32 493 09 73 66 [email protected] ...See details»
BioSenic on its way to find the necessary funds to perform its key ...
Dec 6, 2023 PRESS RELEASE – INSIDE INFORMATION Biosenic signs term sheet with SPRIM Global Investments (TrialCap fund) for up to USD 8 million debt financing and USD …See details»
BioSenic SA - Drug pipelines, Patents, Clinical trials - Synapse
Explore BioSenic SA with its drug pipeline, therapeutic area, technology platform, 15 clinical trials, 140 news, Disease Domain:Hemic and Lymphatic Diseases, Immune System Diseases, …See details»
BioSenic provides third quarter 2024 Business Update - Yahoo …
Oct 28, 2024 BioSenic provides third quarter 2024 Business Update BioSenic is actively seeking one or more new assets through a merger or acquisition process Mont-Saint-Guibert, Belgium, …See details»
BioSenic - Funding, Financials, Valuation & Investors - Crunchbase
Sep 14, 2023 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 2, …See details»
BioSenic appoints Dr Carole Nicco as Chief Scientific Officer
Jan 18, 2023 Dr Nicco will oversee the development of pipeline across BioSenic’s cell therapy and autoimmune disease platform and will be responsible for R&D programs Mont-Saint …See details»
BioSenic S.A. : Transparency notification received from ABO
Oct 7, 2024 REGULATED INFORMATION. Article 14 of the Law of 2 May 2007 on disclosure of major holdings. Mont-Saint-Guibert, Belgium, October 7, 2024, 7:00 CEST – BIOSENIC …See details»
Press Release Distribution and Management - GlobeNewswire
INFORMATION PRIVILIGIEE Mont-Saint-Guibert, Belgique, le 17 septembre 2024, 7h00 CEST – BIOSENIC (Euronext Bruxelles et Paris : BIOS), la société en phase clinique spécialisée dans …See details»
BioSenic announces 2022 full year results
Apr 27, 2023 BioSenic S.A. • Rue Granbonpré 11 - Building H (box 24) • 1435 Mont-St-Guibert • Belgium (Europe) • Phone: +32 (0)493 09 73 66 www.biosenic.com 27/04/2023 3 PRESS …See details»
Bone Therapeutics breaks off old name, rebrands as BioSenic
Oct 26, 2022 BioSenic becomes the fourth biotech to rename itself in the past two months. In late September, CytRx became LadRx as the biotech looks to shrug of years off trial setbacks …See details»
BioSenic - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 BioSenic uses 9 technology products and services including HTML5, Google Analytics, and Google Fonts, according to G2 Stack. BioSenic is actively using 14 …See details»
Medsenic, BioSenic’s subsidiary, signed a new set of
Feb 7, 2024 BioSenic is a leading biotech company specializing in the development of clinical assets issued from its Medsenic’s arsenic trioxide (ATO) platform. Key target indications for …See details»
BioSenic and Pluristyx sign term sheet for market availability of …
May 24, 2023 INSIDE INFORMATION Potential license agreement to produce and commercialize original and transformed ALLOB cells BioSenic to potentially receive royalty …See details»
Our Science - BioSenic
BioSenic focuses on two therapeutic areas: control of innate immunity and tissue repair, for a return to normal function. Their common challenge: the control of inflammation. In the field of …See details»
Home | BioSenic
BioSenic propose un traitement de valeur unique en développant deux gammes de produits innovants : un traitement pour des maladies auto-immunes, à base de Trioxyde d’Arsenic, et …See details»
Medsenic - Crunchbase Company Profile & Funding
Medsenic is a private drug development company. Medsenic is a privately held company that manufactures drugs for the treatment of autoimmune diseases.See details»
Bone Therapeutics - Crunchbase Company Profile & Funding
Bone Therapeutics is a biopharmaceutical company developing cell therapy products for the treatment of osteo-articular diseases.See details»